TIAA CREF INVESTMENT MANAGEMENT LLC - FIVE PRIME THERAPEUTICS INC ownership

FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 175 filers reported holding FIVE PRIME THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
TIAA CREF INVESTMENT MANAGEMENT LLC ownership history of FIVE PRIME THERAPEUTICS INC
ValueSharesWeighting
Q1 2019$2,776,000
+146.5%
207,152
+71.1%
0.00%
+100.0%
Q4 2018$1,126,000
-40.0%
121,042
-10.2%
0.00%0.0%
Q3 2018$1,876,000
+71.6%
134,720
+94.9%
0.00%0.0%
Q2 2018$1,093,000
-13.2%
69,122
-5.7%
0.00%0.0%
Q1 2018$1,259,000
-9.9%
73,270
+14.9%
0.00%0.0%
Q4 2017$1,398,000
-53.9%
63,756
-14.0%
0.00%
-50.0%
Q3 2017$3,033,000
+15.9%
74,134
-14.7%
0.00%0.0%
Q2 2017$2,617,000
-45.3%
86,902
-34.3%
0.00%
-33.3%
Q1 2017$4,784,000
-45.3%
132,342
-24.2%
0.00%
-57.1%
Q4 2016$8,753,000
-9.0%
174,676
-4.7%
0.01%
+16.7%
Q3 2016$9,620,000
+26.5%
183,282
-0.3%
0.01%0.0%
Q2 2016$7,603,000
+31.9%
183,869
+29.6%
0.01%
+50.0%
Q1 2016$5,764,000
-0.8%
141,867
+1.3%
0.00%0.0%
Q4 2015$5,810,000
+163.3%
139,996
-2.4%
0.00%
+100.0%
Q3 2015$2,207,000
-38.9%
143,429
-1.3%
0.00%
-33.3%
Q2 2015$3,610,000
+32.2%
145,343
+21.6%
0.00%
+50.0%
Q1 2015$2,730,000
+77.9%
119,494
+110.2%
0.00%
+100.0%
Q4 2014$1,535,000
+106.6%
56,840
-10.2%
0.00%0.0%
Q3 2014$743,000
-26.1%
63,307
-2.1%
0.00%0.0%
Q2 2014$1,005,000
+151.2%
64,655
+217.7%
0.00%
Q1 2014$400,000
+57.5%
20,350
+34.3%
0.00%
Q4 2013$254,00015,1500.00%
Other shareholders
FIVE PRIME THERAPEUTICS INC shareholders Q4 2016
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 115,500$2,531,0000.89%
AWM Investment Company, Inc. 150,000$3,288,0000.64%
BB BIOTECH AG 827,500$18,139,0000.51%
Virtus ETF Advisers LLC 17,371$381,0000.48%
Rock Springs Capital Management LP 425,000$9,316,0000.42%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 450,728$9,880,0000.39%
Telemetry Investments, L.L.C. 44,176$968,0000.37%
RTW INVESTMENTS, LP 100,377$2,200,0000.37%
Eventide Asset Management 315,000$6,905,0000.36%
ACUTA CAPITAL PARTNERS, LLC 52,500$1,151,0000.22%
View complete list of FIVE PRIME THERAPEUTICS INC shareholders